logo

ADXN

Addex Therapeutics·NASDAQ
--
--(--)
--
--(--)

ADXN fundamentals

Addex Therapeutics (ADXN) expects to report earnings on Mar 9, 2026, with estimated revenue of 236.62K (YoY 0.00%), and EPS at 0 (YoY 0.00%).
Revenue estimate / YoY
236.62K
0.00%
EPS estimate / YoY
0
0.00%
Report date
Mar 9, 2026
EPS
Revenue

Revenue & Expenses

ADXN has released its 2025 Q3 earnings report, with revenue of 62.26K, reflecting a YoY change of -9.89%, and net profit of -1.98M, showing a YoY change of -9.27%. The Sankey diagram below clearly presents ADXN's revenue sources and cost distribution.

Key Indicators

Addex Therapeutics (ADXN) key financial stats and ratios, covering profitability, financial health, and leverage.
Addex Therapeutics (ADXN)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Addex Therapeutics (ADXN)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Addex Therapeutics (ADXN)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Addex Therapeutics (ADXN) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Addex Therapeutics (ADXN) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield